- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04321772
Muscle Response to High Intensity Interval Resistance Training (HIIRT) (HIIRT)
March 24, 2020 updated by: Antonio Paoli, University of Padova
Effects of Exercise Intensity and Rest Intervals on Intracellular Signals and Anabolic Response of Skeletal Muscle to Resistance Training
Resistance training (RT) is one of the most important stimuli for muscle hypertrophy and it plays an important role on weight loss and fatty acid oxidation increase.
RT affects anabolic pathways but the differences among various training techniques has been till now were poorly investigated.
The aim of this study was to compare the effect of two different intensity of training, high-intensity interval resistance training (HIIRT) and traditional resistance training (TRT), on muscle signalling pathway.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Nine young healthy subjects performed HIIRT and TRT protocol in two different moments and with different legs.
HIIRT technique consisted of three sets of: 6 repetitions at 6RM (6 repetitions maximum) and then 20 seconds of rest and 2/3 repetitions (until exhaustion) repeated for 3 times with 2'30" rest between sets; while TRT consisted of 3 sets of 15 reps with 75 sec of rest between sets.
Biopsies from the vastus lateralis were taken at baseline (pre), immediately (0h) at the end of training, 6 hours (6h) and 24 hours (24h) after training.
Western blot and RT-PCR mRNA (Reverse transcriptase-polymerase chain reaction) analysis were performed to assess muscle signalling pathway activation
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Padova, Italy, 35131
- Nutrition and Exercise Lab, DSB, University of Padova
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- moderate active
- experience with resistance training
Exclusion Criteria:
- history of recent myocardial infarction,
- severe cardiac arrhythmia,
- unstable angina,
- poorly controlled hypertension,
- poorly controlled diabetes mellitus,
- frequent or complex ventricular ectopy which might interfere with one's ability to adhere to exercise protocols
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: High Intensity Interval Resistance Training (HIIRT)
HIIRT technique consisted of three sets of: 6 repetitions at 80% 1RM (1 repetition maximum) and then 20 seconds of rest and 2/3 repetitions (until exhaustion) repeated for 3 times with 2'30" rest between sets; while TRT consisted of 3 sets of 15 reps with 75 sec of rest between sets.
|
Subjects trained one leg with HIIRT
|
ACTIVE_COMPARATOR: Traditional Resistance Training (TRT)
TRT protocol performed 3 series of 15 repetitions at 60% 1RM with 75" of rest between sets.
|
Subjects trained the other leg with HIIRT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pAMPKThr172 in skeletal muscle tissue measured by immunoblot
Time Frame: 24 hours
|
measurement of pAMPKThr172 in skeletal muscle tissue taken by biopsy
|
24 hours
|
pERK 1/2Thr202/Tyr204 in skeletal muscle tissue measured by immunoblot
Time Frame: 24 hours
|
measurement of pERK 1/2Thr202/Tyr204 in skeletal muscle tissue taken by biopsy
|
24 hours
|
pS6Ser235/236 in skeletal muscle tissue measured by immunoblot
Time Frame: 24 hours
|
measurement of pS6Ser235/236 in skeletal muscle tissue taken by biopsy
|
24 hours
|
p4EBP1Thr37/46 in skeletal muscle tissue measured by immunoblot
Time Frame: 24 hours
|
measurement of p4EBP1Thr37/46 in skeletal muscle tissue taken by biopsy
|
24 hours
|
ACC (acetyl-coenzyme A carboxylase) phosphorylation in skeletal muscle tissue measured by immunoblot
Time Frame: 24 hours
|
ACC phosphorylation in skeletal muscle tissue taken by biopsy
|
24 hours
|
IGF-1 mRNA (messenger ribonucleic acid) in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
IGF-1 mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
IGF-1ea (insulin like growth factor) mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hoursn
|
IGF-1ea mRNA in skeletal muscle tissue taken by biopsy
|
24 hoursn
|
MGF (mechanical growth factor) mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
MGF mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
STARS mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hoursn
|
STARS mRNA in skeletal muscle tissue taken by biopsy
|
24 hoursn
|
Myogenin mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
Myogenin mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
IL-6 (interleukin 6) mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
IL-6 mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
PGC1a4 (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 4) mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
PGC1a4 mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
PGC1a (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha) mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
PGC1a mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
Atrogin mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
Atrogin mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
Beclin mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
Beclin mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
Myostatin mRNA in skeletal muscle tissue measured by Quantitative polymerase chain reaction (qPCR)
Time Frame: 24 hours
|
Myostatin mRNA in skeletal muscle tissue taken by biopsy
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Antonio Paoli, MD, University of Padova
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Paoli A. Resistance training: the multifaceted side of exercise. Am J Physiol Endocrinol Metab. 2012 Feb 1;302(3):E387. doi: 10.1152/ajpendo.00541.2011. No abstract available.
- Paoli A, Moro T, Marcolin G, Neri M, Bianco A, Palma A, Grimaldi K. High-Intensity Interval Resistance Training (HIRT) influences resting energy expenditure and respiratory ratio in non-dieting individuals. J Transl Med. 2012 Nov 24;10:237. doi: 10.1186/1479-5876-10-237.
- Paoli A, Pacelli QF, Cancellara P, Toniolo L, Moro T, Canato M, Miotti D, Reggiani C. Myosin isoforms and contractile properties of single fibers of human Latissimus Dorsi muscle. Biomed Res Int. 2013;2013:249398. doi: 10.1155/2013/249398. Epub 2013 Jul 22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2012
Primary Completion (ACTUAL)
May 15, 2012
Study Completion (ACTUAL)
February 10, 2013
Study Registration Dates
First Submitted
March 19, 2020
First Submitted That Met QC Criteria
March 24, 2020
First Posted (ACTUAL)
March 25, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 25, 2020
Last Update Submitted That Met QC Criteria
March 24, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- HIIRT12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise
-
Faculdade de Motricidade HumanaCompletedGreen Exercise | Indoor ExercisePortugal
-
Hasan Kalyoncu UniversityNot yet recruiting
-
University of HawaiiKlein Buendel, Inc.CompletedMomZing Exercise Videos Online | Standard Exercise DVDUnited States
-
Istanbul Medipol University HospitalCompletedPulmonary Rehabilitation | Exercise Capacity | Exercise TestTurkey
-
University Hospital MuensterGerman Federal Ministry of Education and ResearchUnknownAerobic Exercise | Anaerobic Exercise | Unchanged ConditionGermany
-
Nathaniel JenkinsCompletedExercise Training | Physical Exertion | Desire to ExerciseUnited States
-
Paracelsus Medical UniversityDepartment of Psychiatry University of BonnRecruitingHealthy | Exercise | Physical Fitness | Exercise TestAustria
-
University of GeorgiaRecruitingBiomarkers | Aerobic Exercise | Acute ExerciseUnited States
-
University of TaipeiCompletedAerobic Exercise | Massage | Anaerobic Exercise
-
University of Alberta, Physical EducationCompletedSedentary Behaviour | Adherence | Traditional Exercise | Lifestyle ExerciseCanada
Clinical Trials on High Intensity Interval Resistance Training
-
Universidad Santo TomasUniversidad del Rosario; Universidad Manuela BeltránCompleted
-
Universidad Santo TomasUniversidad Nacional de Colombia; Universidad del RosarioCompletedObesity | Cognitive Function | Motor ActivityColombia
-
Cliniques universitaires Saint-Luc- Université...CompletedHead and Neck Cancer | Prostate Cancer | Rectum CancerBelgium
-
University of TorontoUniversity Health Network, TorontoTerminated
-
University of NottinghamActive, not recruitingColorectal Cancer | Prostate CancerUnited Kingdom
-
Riphah International UniversityCompletedPolycystic Ovary SyndromePakistan
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
University of NottinghamActive, not recruiting
-
Svehlik Martin, MD PhDUniversity of GrazCompleted